Proventil and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Proventil (albuterol) and Brilinta (ticagrelor). Common drug interactions include cardiac failure congestive among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Proventil and Brilinta. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Proventil?

Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.



On Jul, 12, 2026

30 people who take Proventil and Brilinta together, and have interactions are studied.

Proventil and Brilinta drug interactions.

What are the common drug interactions of Proventil and Brilinta, by gender? *:

female:

  1. Cardiac failure congestive
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Headache (pain in head)
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Dyspnoea (difficult or laboured respiration)
  6. Acute myocardial infarction (acute heart attack)
  7. Anxiety
  8. Arrhythmia (irregular heartbeat)
  9. Bedridden
  10. Brain injury

male:

  1. Sinusitis (inflammation of sinus)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  5. Osteoporosis (bones weak and more likely to break)
  6. Pain
  7. Bone density decreased
  8. Cardiac failure congestive
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Chest pain

What are the common drug interactions of Proventil and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Presyncope
  2. Chronic kidney disease

50-59:

  1. Cardiac failure congestive
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Arrhythmia (irregular heartbeat)
  6. Bedridden
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cough
  9. Emotional distress
  10. Heart injury

60+:

  1. Rash pruritic (redness with itching)
  2. Sinusitis (inflammation of sinus)
  3. Acute respiratory failure
  4. Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
  5. Back pain
  6. Blood glucose increased
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiac failure
  9. Cardiac failure congestive
  10. Cardiomyopathy (weakening of the heart muscle)

What are the existing conditions these people have? *

  1. Chest Pain: 6 people, 20.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.67%
  3. Dyspnea (difficult or laboured breathing): 4 people, 13.33%
  4. Pain: 4 people, 13.33%
  5. High Blood Cholesterol: 4 people, 13.33%
  6. Neuropathy Peripheral (surface nerve damage): 4 people, 13.33%
  7. Immunodeficiency Common Variable: 4 people, 13.33%
  8. Depression: 3 people, 10.00%
  9. Diabetes: 3 people, 10.00%
  10. Muscle Spasms (muscle contraction): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Proventil and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Proventil and Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Proventil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Brilinta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proventil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Brilinta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol and ticagrelor (the active ingredients of Proventil and Brilinta, respectively), and Proventil and Brilinta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: